# FDA Inspection 734259 - Regenerative Biologics, Inc. - July 12, 2011

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/3f8b7426-0f6a-4a51-b8da-ccb8d863d8ee
Source feed: FDA_Inspections

> FDA Inspection 734259 for Regenerative Biologics, Inc. on July 12, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 734259
- Company Name: Regenerative Biologics, Inc.
- Inspection Date: 2011-07-12
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1020144 - 2017-06-14](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/575153e7-a1fc-4203-87b7-a37057417fca)
- [FDA Inspection 934502 - 2015-07-10](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/d5dd1118-323b-45c7-94fc-133b4e759d35)
- [FDA Inspection 824233 - 2013-03-29](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/d44529b2-652c-4e4b-99c6-8a9548f9d2bf)

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/0d27157d-3fca-49d5-a7b7-d703126a6a1b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d